Sunitinib Bluefish

Sunitinib Bluefish is an oral prescription medication used for certain types of cancer treatment. It belongs to a class of drugs known as kinase inhibitors. This product is manufactured by Bluefish Pharmaceuticals Ab and is available in the EU market.

Sunitinib is primarily used to treat specific cancers, including gastrointestinal stromal tumors (GIST) after disease progression or intolerance to imatinib, advanced renal cell carcinoma (RCC), and progressive pancreatic neuroendocrine tumors (pNET). It works by slowing or stopping the growth of cancer cells. Patients often ask, 'what is Sunitinib used for' to understand its therapeutic applications in oncology.

Sunitinib may help manage cancer symptoms by targeting abnormal cell growth. Common effects include fatigue, digestive changes, and skin discoloration. Some users report reduced tumor-related discomfort over time. These effects vary by individual and should be monitored by a healthcare provider.

Handle Sunitinib with care, as it is a potent medication. Store it in a cool, dry place away from children and pets. Avoid crushing or splitting tablets unless instructed. Always follow the handling instructions provided with the medication to ensure safety.

Sunitinib can interact with other medications, including strong CYP3A4 inhibitors or inducers, which may alter its effectiveness. Grapefruit products and certain antibiotics or antifungals can also interact. Discuss all current medications with a healthcare provider before starting Sunitinib to avoid potential complications.